Invest in startups from as little as 250 with the new minimum investment amount.

Simple - digital - fast.

ARESUS PHARMA GMBH - Overview

More Startups
Legal notice: The acquisition of this security is associated with considerable risks and can lead to the complete loss of the invested assets. The expected return is not guaranteed and may be lower than expected.
Aresus Pharma has acquired a medication that has been launched on the market. Benefit from a positive cash flow and a high growth potential.


Note

This document is used to advertise the security. A basic information sheet has been published for this security offer. This can be downloaded from www.companisto-trust-service.de/i/bib. The information about the companies on the Companisto website is provided exclusively by the companies.

Equity
€ 771,363

Financed

153

Investors

Please note

The acquisition of the offered securities and investments is associated with considerable risks and can lead to the complete loss of the invested assets. The expected yield is not guaranteed and may be lower. Whether it is a security or an asset investment can be seen in the description of the investment opportunity.
×
View in Companisto App
Open